查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2100079

介入性神經外科醫療設備市場－2026-2032年全球市場預測

Interventional Neurology Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，介入性神經醫療設備市場將成長至 44.8 億美元，複合年成長率為 9.44%。

主要市場統計數據
基準年 2025 23.8億美元
預計年份：2026年 26.2億美元
預測年份：2032年 44.8億美元
複合年成長率 (%) 9.44%

介入性神經外科醫療設備在中風治療和神經血管疾病治療的現代化過程中發揮核心作用，能夠以微創方式治療缺血性中風、出血性中風、顱內動脈瘤、動靜脈畸形、頸動脈疾病和其他複雜的腦血管疾病。全球神經系統疾病負擔的加重、卒中診療中心網路的擴展、機械取栓術的廣泛應用、神經血管影像技術的進步以及越來越多的臨床證據支持對合格的患者進行及時的血管內治療，共同推動了醫療器械的需求成長。主要醫療設備類別包括血栓摘取支架取栓器、抽吸導管、微導管、導管導引線、液體栓塞系統、球囊導管、頸動脈支架以及用於在精細腦血管系統中進行精確導航的通路系統。

這一領域日益注重速度、安全性和工作流程整合。醫院和中風中心優先採用能夠縮短從轉運到影像檢查、從轉運到穿刺以及再灌注治療的時間，提高首次穿刺成功率，減少手術併發症並支持多學科治療決策的技術。同時，由於中風治療的時效性極強，醫療系統面臨將服務範圍擴大到大型大學醫院以外的壓力。這造就了一種策略環境：醫療設備創新、醫務人員培訓、保險報銷方案調整、影像基礎設施以及區域卒中護理系統與產品性能同等重要。

介入神經放射學領域的變革性變化

隨著神經血管介入手術從高度專業化的三級醫療機構轉向涵蓋範圍更廣、軸輻式模式運作的卒中網路，介入神經放射學醫療設備領域正經歷著變革。在指引指導和隨機臨床試驗證據的支持下，針對大血管閉塞的機械取栓術正加速應用於臨床，這些試驗表明，快速、適當地篩選和治療患者能夠改善其功能預後。這促使人們更加關注卒中診療流程的整合，包括院前分診、移動卒中單元、先進的CT和MRI成像、灌注分析以及簡化的轉運方案。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過提高整個中風診療流程的速度、一致性和協調性，對介入神經放射學領域產生了累積的影響。 AI 驅動的影像工具正被擴大用於輔助檢測主要血管閉塞、量化缺血核心和缺血半暗帶、識別顱內出血，並向中風團隊提供近乎即時的警報。這些功能有助於減少診斷和轉運決策的延誤，尤其是在專科醫生資源因地區而異的區域網路中。雖然 AI 不能取代臨床判斷，但它透過優先處理高優先病例並規範急診、放射科團隊、神經科醫生和介入神經放射學之間的資訊共用，提高了工作流程效率。

神經血管護理方面的關鍵區域見解

在亞太地區，由於中風發病率上升、人口老化、三級醫療機構容量擴大以及對神經血管護理基礎設施投資增加，介入神經放射學醫療設備的戰略重要性日益凸顯。中國、日本、印度、韓國和澳洲的部署環境各不相同，既有成熟的介入神經放射學中心，也有快速發展的區域中風網路。日本和韓國正充分利用其在先進成像技術和專家經驗方面的廣泛應用優勢，而中國和印度則透過升級醫院設備、加強醫生培訓以及意識提升，不斷擴大治療覆蓋範圍。在東協，血管內中風治療能力正在逐步提高，但都市區之間的醫療資源取得仍存在差距。

用於策略定位的關鍵群體洞察

在東協，新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國的中風治療能力發展速度不一，導致介入神經放射學醫療設備的需求情況各異，但其重要性卻日益凸顯。儘管新加坡和東協經濟區主要城市的醫院擁有先進的成像技術和血管內介入治療技術，但許多區域性城市在緊急應變、保險報銷和訓練有素的介入神經放射學人員方面仍然面臨挑戰。此領域的進展取決於中風治療的協調、區域訓練舉措以及CT血管攝影檢查和介入手術室的普及。

主要國家介入神經放射學介入醫療設備的發展趨勢

美國在介入神經放射學器械的部署方面處於世界領先地位，這得益於其完善的卒中中心認證體系、成熟的血管內培訓項目、先進的成像技術以及對合格的大血管閉塞患者廣泛應用機械取栓術。加拿大的情況則取決於其省級中風醫療保健系統、集中化的專科化管理以及對地域分散的人口公平獲取醫療服務的高度重視。在墨西哥，主要大都會圈的醫院正在擴展介入神經放射學能力，但其部署受到公立和私立醫療保健差異、急救轉運能力不足以及專科醫生數量有限等因素的影響。在巴西，主要都市區存在巨大的臨床需求，神經血管領域的專業技術也在不斷發展，但由於基礎設施和保險報銷方面的區域差異，更廣泛的醫療服務取得受到限制。

業界領導者使用的實用建議

業界領導者應優先考慮經臨床驗證的創新技術，這些技術能夠改善中風和神經血管手術的可衡量療效，包括加快再灌注、提高首次手術成功率、提升手術導航安全性、降低併發症發生率以及與現代影像工作流程的兼容性。產品開發應緊密結合實際手術挑戰，例如複雜的解剖結構、遠端閉塞、血栓異質性、動脈瘤形態以及對可靠入路系統的需求。實證醫學證據的取得仍然至關重要，應利用前瞻性臨床試驗、註冊登記和上市後監測來證明產品的安全性、有效性和對工作流程的價值。

調查方法

介入性神經醫療設備的調查方法結合了結構化的二手資料研究、一手資料檢驗和證據三角檢驗。二手資料研究包括同儕審查的臨床文獻、國際中風指南、監管資料庫庫、醫院認證框架、公共衛生資料集、保險報銷參考資料以及與機械取栓術、動脈瘤治療、栓塞術、頸動脈介入治療和神經血管通路技術相關的科學期刊。研究尤其關注與患者預後、手術安全性、治療時間窗、影像選擇和工作流程效率相關的臨床證據。

結論

介入性神經外科醫療設備正在改變中風和腦血管疾病的治療方式，使治療能夠更快、更微創、更精準地進行，尤其適用於那些時間和精準度直接影響治療結果的疾病。這一領域的發展得益於血栓切除平台、栓塞系統、血流改道技術、介入醫療設備、影像整合以及人工智慧驅動的工作流程調整等方面的改進。雖然在擁有完善的中風診療體系、訓練有素的專家、完善的醫保報銷機制和先進的影像基礎設施的地區，這些器械的應用最為廣泛，但在許多新興醫療機構和農村醫療環境中，醫療資源獲取方面的差距仍然是一個重大挑戰。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 介入性神經外科醫療設備市場：依產品類型分類

  • 栓塞劑
    • 液態栓塞劑
    • 微球
    • 顆粒栓子
  • 血液循環旁路醫療設備
    • FRED
    • Pipeline
    • Surpass Streamlines
  • 神經血管線圈
    • 生物活性線圈
    • 水凝膠線圈
    • 鉑金線圈
  • 神經血管支架
    • 球囊擴張支架
    • 自膨式支架
  • 血栓切除術醫療設備
    • 吸痰管
    • 血栓摘取支架

第8章 介入性神經醫療設備市場：依技術分類

  • 導管導引線系統
    • 親水塗層
    • 聚合物塗層
  • 機械血栓切除術
  • 微導管系統
    • 導絲引導式微導管
    • 快速交換微導管
  • 溶栓劑
    • tPA
    • 尿激酶

第9章 介入性神經醫療設備市場：依應用領域分類

  • 動脈瘤
  • 動靜脈畸形
  • 頸動脈狹窄
  • 缺血性中風
  • 血管痙攣

第10章 介入性神經醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 影像中心
  • 醫院
  • 介入神經放射學診所

第11章 介入性神經醫療設備市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 介入性神經醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 介入性神經醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Asahi Intecc Co., Ltd.
  • Balt Extrusion SA
  • Boston Scientific Corporation
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Kaneka Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Terumo Corporation
  • Wallaby Medical, Inc.
Product Code: MRR-742BD517FEBA

The Interventional Neurology Devices Market is projected to grow by USD 4.48 billion at a CAGR of 9.44% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.38 billion
Estimated Year [2026] USD 2.62 billion
Forecast Year [2032] USD 4.48 billion
CAGR (%) 9.44%

Interventional neurology devices are central to the modernization of stroke care and neurovascular treatment, enabling minimally invasive management of ischemic stroke, hemorrhagic stroke, intracranial aneurysms, arteriovenous malformations, carotid artery disease, and other complex cerebrovascular conditions. Demand is shaped by the global burden of neurological disease, expanding stroke-ready hospital networks, greater use of mechanical thrombectomy, advances in neurovascular imaging, and stronger clinical evidence supporting timely endovascular intervention for eligible patients. Key device categories include stent retrievers, aspiration catheters, microcatheters, guidewires, embolic coils, flow diverters, liquid embolic systems, balloon catheters, carotid stents, and access systems designed for precise navigation through delicate cerebral vasculature.

The sector is increasingly defined by speed, safety, and workflow integration. Hospitals and stroke centers are prioritizing technologies that shorten door-to-imaging, door-to-puncture, and reperfusion times; improve first-pass effect; reduce procedural complications; and support treatment decisions across multidisciplinary teams. At the same time, healthcare systems face pressure to expand access beyond major academic centers, as stroke outcomes remain highly time-dependent. This creates a strategic environment in which device innovation, operator training, reimbursement alignment, imaging infrastructure, and regional stroke systems of care are as important as product performance.

Transformative Shifts in the Neurointerventional Landscape

The interventional neurology devices landscape is undergoing transformative change as neurovascular procedures move from highly specialized tertiary settings toward broader hub-and-spoke stroke networks. Clinical adoption has accelerated around mechanical thrombectomy for large vessel occlusion, supported by guideline-based care pathways and randomized clinical evidence demonstrating improved functional outcomes when patients are treated rapidly and appropriately selected. This has intensified focus on integrated stroke workflows, including prehospital triage, mobile stroke units, advanced CT and MR imaging, perfusion analysis, and streamlined transfer protocols.

Device development is shifting toward improved deliverability, softer distal access, stronger clot integration, enhanced aspiration efficiency, and lower-profile systems that can address anatomically challenging lesions. In aneurysm care, flow diversion, adjunctive coiling, and intrasaccular technologies continue to influence treatment approaches, while embolization platforms are expanding options for complex vascular malformations. Regulatory expectations are also evolving, with stronger emphasis on clinical evidence, post-market surveillance, real-world performance, and device traceability. Across healthcare systems, the most meaningful transformation is the convergence of devices, imaging, digital workflow, physician training, and patient selection into end-to-end neurointerventional care models.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force in interventional neurology by improving speed, consistency, and coordination across the stroke care continuum. AI-enabled imaging tools are increasingly used to support detection of large vessel occlusion, quantify ischemic core and penumbra, identify intracranial hemorrhage, and alert stroke teams in near real time. These capabilities can help reduce delays in diagnosis and transfer decisions, especially in regional networks where specialist availability varies. AI does not replace clinical judgment, but it strengthens workflow efficiency by prioritizing urgent cases and standardizing information flow between emergency departments, radiology teams, neurologists, and neurointerventionalists.

The impact of AI extends beyond acute triage. Procedure planning may benefit from automated vessel segmentation, anatomy assessment, and device sizing support, while intraoperative imaging analytics can improve visualization and decision-making. Over time, AI-driven registries and real-world evidence platforms can enhance quality benchmarking, complication tracking, and outcome analysis for neurovascular procedures. However, adoption depends on validation across diverse patient populations, interoperability with hospital systems, cybersecurity safeguards, regulatory clearance, and transparent performance monitoring. The most successful implementations will be those that integrate AI into clinically governed workflows rather than treating it as a standalone technology layer.

Key Regional Insights Across Neurovascular Care

Asia-Pacific is gaining strategic importance in interventional neurology devices due to rising stroke prevalence, aging populations, expanding tertiary hospital capacity, and increasing investment in neurovascular care infrastructure. China, Japan, India, South Korea, and Australia represent distinct adoption environments, ranging from mature neurointerventional centers to fast-developing regional stroke networks. Japan and South Korea benefit from advanced imaging penetration and specialist expertise, while China and India continue to expand access through hospital upgrades, physician training, and broader public awareness of time-sensitive stroke treatment. ASEAN countries are gradually improving endovascular stroke care capabilities, although access remains uneven between urban centers and rural regions.

North America remains a highly developed environment for interventional neurology devices, supported by established comprehensive stroke centers, advanced imaging workflows, specialist training pathways, and reimbursement structures that support acute stroke intervention. The United States has strong adoption of mechanical thrombectomy and aneurysm treatment technologies, while Canada emphasizes coordinated provincial stroke systems and evidence-based care delivery. Europe demonstrates broad clinical sophistication across major economies, with adoption shaped by national health technology assessment, public reimbursement frameworks, and cross-border clinical guideline alignment. Germany, France, the United Kingdom, Italy, and Spain maintain strong neurointerventional capacity, while access levels vary across Eastern and Southern Europe.

Latin America is progressing as major urban hospitals expand neurointerventional services, particularly in Brazil and Mexico, but disparities in emergency transport, imaging availability, reimbursement, and specialist density continue to affect timely care. The Middle East is investing in advanced hospital infrastructure, stroke centers, and specialist recruitment, especially across Gulf countries, where public and private healthcare modernization supports adoption of high-acuity neurovascular procedures. Africa remains the most access-constrained region, with limited neurointerventional infrastructure in many countries; however, selected urban centers are building capacity through specialist training, international collaboration, and gradual improvements in imaging and emergency care systems.

Key Group Insights for Strategic Positioning

ASEAN presents a mixed but increasingly important opportunity for interventional neurology devices as countries such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines develop stroke care capabilities at different speeds. Singapore and leading urban hospitals in larger ASEAN economies have advanced imaging and endovascular expertise, while many secondary cities still face gaps in emergency response, reimbursement, and trained neurointerventional staff. The group's progress depends on coordinated stroke pathways, regional training initiatives, and broader access to CT angiography and interventional suites.

The GCC is characterized by substantial healthcare infrastructure investment, high prioritization of advanced specialty care, and growing demand for comprehensive stroke center capabilities. Countries in the group are strengthening emergency medicine, digital health, and tertiary care networks, supporting adoption of mechanical thrombectomy, aneurysm embolization, and other neurovascular procedures. The European Union benefits from harmonized medical device regulation, mature clinical guideline adoption, and strong public healthcare systems, although procurement processes, reimbursement rules, and capacity vary by member state. EU hospitals increasingly emphasize evidence-based device selection, procedural safety, and post-market clinical performance.

BRICS countries collectively represent high patient need and diverse adoption pathways. China and India are expanding neurointerventional capacity through hospital infrastructure, specialist training, and broader imaging access, while Brazil and South Africa are building access primarily through major urban centers, and Russia maintains specialized neurovascular expertise within a complex healthcare environment. The G7 group reflects mature technology adoption, advanced imaging availability, and structured stroke care systems across the United States, Canada, Japan, Germany, France, Italy, and the United Kingdom. NATO countries overlap with many high-income healthcare systems in North America and Europe, where emergency preparedness, hospital modernization, and interoperable care networks can support advanced neurovascular treatment capacity, although healthcare delivery remains nationally governed rather than alliance-directed.

Key Country Insights in Interventional Neurology Devices

The United States is a leading adopter of interventional neurology devices, supported by comprehensive stroke center certification, established endovascular training, advanced imaging, and broad use of mechanical thrombectomy for eligible large vessel occlusion patients. Canada's environment is shaped by provincial stroke systems, centralized specialty care, and a strong emphasis on equitable access across geographically dispersed populations. Mexico is expanding neurointerventional capabilities in major metropolitan hospitals, with adoption influenced by public-private healthcare differences, emergency transfer limitations, and specialist availability. Brazil has significant clinical need and growing neurovascular expertise in leading urban centers, while broader access is constrained by regional disparities in infrastructure and reimbursement.

In Europe, the United Kingdom continues to strengthen thrombectomy access through national stroke planning, although timely coverage remains an operational priority. Germany has extensive hospital infrastructure and strong neurointerventional capacity, supported by advanced imaging and specialist networks. France emphasizes structured stroke care pathways and public reimbursement oversight, while Italy and Spain combine strong clinical expertise with regional variation in procedure access and hospital resources. Russia maintains experienced neurovascular centers in major cities, but access can vary widely across regions due to geography, funding, and infrastructure distribution.

China is rapidly expanding neurointerventional services through hospital investment, physician training, and increasing adoption of advanced stroke and aneurysm care technologies. India has a high stroke burden and growing capability in private and tertiary hospitals, but access remains uneven due to affordability, emergency transport, and specialist concentration in large cities. Japan has mature neurovascular practice, advanced imaging availability, and an aging population that sustains demand for minimally invasive cerebrovascular treatment. Australia benefits from organized stroke networks and high-quality tertiary care, though geography creates challenges in rapid access for remote communities. South Korea combines advanced hospital infrastructure, strong digital health capabilities, and highly developed specialist care, supporting sophisticated adoption of interventional neurology devices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves measurable outcomes in stroke and neurovascular procedures, including faster reperfusion, higher first-pass success, safer navigation, reduced complication rates, and compatibility with modern imaging workflows. Product development should be closely aligned with real-world procedural challenges such as tortuous anatomy, distal occlusions, clot heterogeneity, aneurysm morphology, and the need for reliable access systems. Evidence generation must remain central, with prospective clinical studies, registry participation, and post-market surveillance used to demonstrate safety, effectiveness, and workflow value.

Commercial strategies should focus on strengthening stroke systems of care rather than device placement alone. This includes physician education, simulation-based training, multidisciplinary workflow support, and partnerships that improve transfer protocols and treatment readiness. In emerging and access-constrained regions, scalable training models, service support, and cost-sensitive portfolios can help expand adoption responsibly. Leaders should also invest in digital integration, including AI-enabled imaging compatibility, data capture, and procedural analytics, while ensuring cybersecurity, regulatory compliance, and transparent clinical governance. Sustainable success will come from combining device performance with evidence, training, workflow efficiency, and regional access strategies.

Research Methodology

The research methodology for analyzing interventional neurology devices combines structured secondary research, primary validation, and evidence triangulation. Secondary research includes peer-reviewed clinical literature, international stroke guidelines, regulatory databases, hospital accreditation frameworks, public health datasets, reimbursement references, and scientific publications related to mechanical thrombectomy, aneurysm treatment, embolization, carotid intervention, and neurovascular access technologies. Particular attention is given to clinically relevant evidence on patient outcomes, procedural safety, treatment windows, imaging selection, and workflow performance.

Primary research inputs typically include discussions with neurologists, neurointerventionalists, neuroradiologists, hospital procurement professionals, clinical engineers, distributors, and healthcare policy stakeholders. These inputs help validate adoption drivers, infrastructure barriers, device selection criteria, training needs, and regional differences in access to neurovascular care. Findings are triangulated across multiple verified sources to reduce bias and ensure consistency. The methodology avoids unsupported assumptions and does not rely on market sizing, market share, or forecasting. Instead, it emphasizes verified clinical, regulatory, operational, and regional intelligence that supports strategic decision-making.

Conclusion

Interventional neurology devices are reshaping the treatment of stroke and cerebrovascular disease by enabling faster, less invasive, and more targeted intervention for conditions where time and precision directly affect outcomes. The field is advancing through better thrombectomy platforms, embolization systems, flow diversion technologies, access devices, imaging integration, and AI-supported workflow coordination. Adoption is strongest where comprehensive stroke systems, trained specialists, reimbursement support, and advanced imaging infrastructure are aligned, while access gaps remain a major challenge in many emerging and rural healthcare environments.

The next phase of progress will depend on evidence-based innovation, real-world performance monitoring, digital workflow integration, and broader training of neurointerventional teams. Regional strategies must reflect the differing maturity of North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa, as well as the specific needs of major country and economic groups. For industry leaders, the central opportunity lies in supporting complete neurovascular care ecosystems that improve speed, safety, and access while meeting increasingly rigorous clinical and regulatory expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Interventional Neurology Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Embolic Agents
    • 7.2.1. Liquid Embolics
    • 7.2.2. Microspheres
    • 7.2.3. Particulate Embolics
  • 7.3. Flow Diversion Devices
    • 7.3.1. Fred
    • 7.3.2. Pipeline Devices
    • 7.3.3. Surpass Streamlines
  • 7.4. Neurovascular Coils
    • 7.4.1. Bioactive Coils
    • 7.4.2. Hydrogel Coils
    • 7.4.3. Platinum Coils
  • 7.5. Neurovascular Stents
    • 7.5.1. Balloon-Expandable Stents
    • 7.5.2. Self-Expanding Stents
  • 7.6. Thrombectomy Devices
    • 7.6.1. Aspiration Catheters
    • 7.6.2. Stent Retrievers

8. Interventional Neurology Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Guidewire Systems
    • 8.2.1. Hydrophilic Coated
    • 8.2.2. Polymer Coated
  • 8.3. Mechanical Thrombectomy
  • 8.4. Microcatheter Systems
    • 8.4.1. Over The Wire Microcatheters
    • 8.4.2. Rapid Exchange Microcatheters
  • 8.5. Thrombolytic Agents
    • 8.5.1. Tpa
    • 8.5.2. Urokinase

9. Interventional Neurology Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Aneurysm
  • 9.3. Arteriovenous Malformations
  • 9.4. Carotid Stenosis
  • 9.5. Ischemic Stroke
  • 9.6. Vasospasm

10. Interventional Neurology Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Center
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospital
  • 10.5. Neuro Interventional Clinics

11. Interventional Neurology Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Interventional Neurology Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Interventional Neurology Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Asahi Intecc Co., Ltd.
  • 15.2. Balt Extrusion S.A.
  • 15.3. Boston Scientific Corporation
  • 15.4. Integer Holdings Corporation
  • 15.5. Johnson & Johnson
  • 15.6. Kaneka Corporation
  • 15.7. Medtronic plc
  • 15.8. MicroPort Scientific Corporation
  • 15.9. MicroVention, Inc.
  • 15.10. Penumbra, Inc.
  • 15.11. Phenox GmbH
  • 15.12. Rapid Medical Ltd.
  • 15.13. Stryker Corporation
  • 15.14. Terumo Corporation
  • 15.15. Wallaby Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MICROSPHERES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROSPHERES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLOW DIVERSION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLOW DIVERSION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLOW DIVERSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FRED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FRED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FRED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PIPELINE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PIPELINE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PIPELINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURPASS STREAMLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURPASS STREAMLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURPASS STREAMLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOACTIVE COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOACTIVE COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOACTIVE COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HYDROGEL COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HYDROGEL COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HYDROGEL COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLATINUM COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PLATINUM COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLATINUM COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STENT RETRIEVERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STENT RETRIEVERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STENT RETRIEVERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GUIDEWIRE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GUIDEWIRE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GUIDEWIRE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HYDROPHILIC COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POLYMER COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POLYMER COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POLYMER COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MICROCATHETER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MICROCATHETER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MICROCATHETER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OVER THE WIRE MICROCATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OVER THE WIRE MICROCATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OVER THE WIRE MICROCATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RAPID EXCHANGE MICROCATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RAPID EXCHANGE MICROCATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RAPID EXCHANGE MICROCATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL THROMBOLYTIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL THROMBOLYTIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL THROMBOLYTIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TPA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TPA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TPA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROKINASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL UROKINASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CAROTID STENOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CAROTID STENOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CAROTID STENOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VASOSPASM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VASOSPASM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VASOSPASM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOSPITAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPITAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOSPITAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEURO INTERVENTIONAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEURO INTERVENTIONAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEURO INTERVENTIONAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. GCC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 260. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 261. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. G7 INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 267. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 273. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 274. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. NATO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 306. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 307. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 308. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 309. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 312. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBOLYTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 319. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 320. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR COILS, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY GUIDEWIRE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICROCATHETER SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY T